Company news
Ligand Pharmaceuticals Incorporated news in 2020
Ligand Pharmaceuticals Incorporated's news releases, calls and decks from 2020, newest first.
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
December 20, 2020
Ligand Announces Clinical and Regulatory Progress by Multiple Partners with OmniAb® Antibodies
November 22, 2020
Ligand’s Partner Sedor Pharmaceuticals Receives FDA Approval for SESQUIENT™ for the Treatment of Status Epilepticus in Adult and Pediatric Patients
November 5, 2020
Ligand Reports Third Quarter 2020 Financial Results
October 29, 2020
Ligand’s Captisol Technology Plays Key Role in the Manufacture of Gilead’s Veklury, the First FDA-Approved COVID-19 Treatment
October 22, 2020
Ligand Provides Highlights from Today’s Investor Day Event
October 19, 2020
Ligand’s Third Quarter Financial Results to be Reported October 30th
October 18, 2020
Ligand to Divest Vernalis Research Operations
October 11, 2020
Ligand to Host Virtual Investor Day on October 20th
October 1, 2020
Ligand Completes Acquisition of Pfenex Inc.
September 30, 2020
Ligand Announces Expiration of Tender Offer for Shares of Pfenex Inc.
September 29, 2020
Ligand Announces its Captisol Business is Positioned for Major Growth and Forecasts 2021 Captisol Material Sales of $200 Million
September 22, 2020
Ligand Expands OmniAb® Antibody Discovery Platform Through the Acquisitions of xCella Biosciences and Taurus Biosciences
September 9, 2020
Ligand Pharmaceuticals Management to Present at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference
August 31, 2020
Ligand Commences Previously Announced Cash Tender Offer to Acquire Pfenex Inc.
August 30, 2020
Ligand OmniAb® Partner Immunovant Announced Positive Topline Results from Multicenter, Placebo-Controlled Phase 2a Trial of IMVT-1401 in Myasthenia Gravis
August 24, 2020
Ligand Announces Amgen’s KYPROLIS® Approved by FDA as Combination Regimen with DARZALEX® and Dexamethasone in Once- and Twice-Weekly Dosing Regimens for Patients with Relapsed/Refractory Multiple Myeloma
August 23, 2020
Ligand to Acquire Pfenex Inc.
August 9, 2020
Ligand Reports Second Quarter 2020 Financial Results
August 2, 2020
Ligand’s Second Quarter Financial Results to be Reported August 3rd
July 15, 2020
Functional, Human Antibodies Targeting SARS-CoV-2 Discovered Using IPA's Proprietary B cell Select™ and Single Step Cloning Hybridoma Technologies
July 12, 2020
Ligand Announces an Expansion of Vernalis Collaboration with Servier for Research on Novel Oncology Targets
June 14, 2020
Ligand CEO Issues Letter to Captisol Customers
May 31, 2020
Ligand Announces Icagen’s Expansion of Collaboration with Roche to Develop and Commercialize Therapies for Neurological Diseases
May 28, 2020
Ligand Earns $3 Million Milestone Payment from Palvella Therapeutics
May 27, 2020
Ligand Reports First Quarter 2020 Financial Results
May 5, 2020
Ligand’s First Quarter Financial Results to be Reported May 6th
April 21, 2020
Ligand Provides a Corporate Update and Announces May 6th as the Date for First Quarter Earnings Call
April 5, 2020
Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs and Ion Channel Technologies
April 1, 2020
Ligand’s Presentation at the Barclays Global Healthcare Conference Now a Webcast Only, New Slides Available on Ligand.com
March 9, 2020
Ligand Pharmaceuticals Management to Present at Two Investor Conferences in March
March 1, 2020
Ligand Raises 2020 Financial Guidance Due to Higher Captisol Material Sales
February 26, 2020
Ligand Agrees to Acquire Core Assets, Partnered Programs and Ion Channel Technologies from Icagen
February 10, 2020
Ligand Reports Fourth Quarter and Full Year 2019 Financial Results
February 5, 2020
Ligand's Technologies Support and Enable Potential Coronavirus Treatments
February 2, 2020
Ligand Enters into OmniAb® Platform License Agreement with Pandion Therapeutics
January 12, 2020
Ligand to Report 2019 Fourth Quarter and Full Year Financial Results on February 6th
January 8, 2020
Decks in 2020
- Investor Day (October 2020)
Investor day · 131 slides · Oct 20, 2020